PALISADE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.91 USD | -4.84% |
|
-22.80% | -44.52% |
| 05-10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
| 05-07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PALISADE BIO, INC. | Other Biotechnology & Medical Research | -4.84% | -22.80% | -44.52% | -77.43% | - | 4.84M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- SNCA Stock
- Charts Palisade Bio, Inc.
- Comparison Chart
